Last $103.16 USD
Change Today +0.99 / 0.97%
Volume 1.7M
ZMH On Other Exchanges
Symbol
Exchange
New York
SIX Swiss Ex
Munich
As of 4:15 PM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

zimmer holdings inc (ZMH) Key Developments

Zimmer Holdings, Inc. Announces Quarterly Dividend for Second Quarter of 2014, Payable on or About July 25, 2014

Zimmer Holdings, Inc. announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2014. The cash dividend of $0.22 per share will be paid on or about July 25, 2014, to stockholders of record as of the close of business on June 27, 2014.

Zimmer Holdings, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2014; Revises Earnings Guidance for the Full Year Ending December 31, 2014

Zimmer Holdings, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2014. For the quarter, the company's net sales were $1,161.5 million against $1,138.9 million a year ago. Operating profit was $298.4 million against $298.2 million a year ago. Earnings before income taxes were $285.9 million against $283.7 million a year ago. Net earnings were $221.1 million against $218.0 million a year ago. Net earnings of Zimmer Holdings, Inc. were $221.5 million or $1.29 diluted per share against $218.6 million or $1.28 diluted per share a year ago. Net cash provided by operating activities was $188.8 million against $180.5 million a year ago. Additions to instruments were $49.4 million against $57.5 million a year ago. Additions to other property, plant and equipment were $31.4 million against $17.9 million a year ago. Adjusted net earnings were $258.1 million or $1.50 diluted per share against $240.8 million or $1.41 diluted per share a year ago. Adjusted operating profit in the quarter amounted to $352 million at 30.3%. The significant improvement in adjusted operating margin in the quarter reflects the progress the company have made in restoring growth to certain geographic markets and higher-margin product categories within musculoskeletal portfolio. The company reaffirmed its full-year revenue and updated earnings guidance for 2014. Full-year revenues are still expected to increase approximately 3.0% to 5.0% on a constant currency basis from 2013. The Company continues to estimate that foreign currency translation will decrease revenues by approximately 0.5% for the full year, resulting in reported revenue growth between 2.5% and 4.5%. The company's earnings guidance has been updated to give effect to a change in the anticipated number of diluted weighted average shares outstanding for 2014. The number is expected to be higher as a result of the discontinuation of previously guided share repurchases ahead of the announced transaction with Biomet. The company now expects full-year 2014 diluted earnings per share to be in a range of $4.90 to $5.10 on a reported basis and $6.00 to $6.20 on an adjusted basis with the higher average shares. Prior guidance for full-year 2014 adjusted diluted earnings per share was $6.10 to $6.30. Consistent with the prior guidance, adjusted diluted earnings per share exclude estimated charges for inventory and manufacturing related expenses, quality and operational excellence initiatives, and special items of $250.0 million on a pre-tax basis, or approximately $1.10 per diluted share, on an after-tax basis. Additional costs connected to the pending transaction with Biomet which are not estimable at this time, shall also be excluded from the adjusted earnings measure.

Zimmer Holdings, Inc. to Report Q1, 2014 Results on Apr 24, 2014

Zimmer Holdings, Inc. announced that they will report Q1, 2014 results at 8:00 AM, US Eastern Standard Time on Apr 24, 2014

Zimmer Holdings, Inc., Q1 2014 Earnings Call, Apr 24, 2014

Zimmer Holdings, Inc., Q1 2014 Earnings Call, Apr 24, 2014

Zimmer Spine, Inc. Launches Comprehensive Line of Puros Demineralized Bone Matrix (DBM) with Reverse Phase Medium (RPM) and Puros DBM Block and Strip Allografts

Zimmer Spine, Inc. announced the U.S. market launch of a comprehensive family of Puros Demineralized Bone Matrix (DBM) with Reverse Phase Medium (RPM) Putty, Putty with Chips, Gel and Paste, and Puros DBM Block and Strip products - bone graft substitutes used to stimulate natural bone formation processes in spine surgical procedures. These products are provided in collaboration with AlloSource (Centennial, CO) and will be launched at the American Association for Neurological Surgeons (AANS) meeting being held April 5-9 in San Francisco. About Puros DBM with RPM Putty, Putty with Chips, Gel and Paste: Puros DBM with RPM products are bone graft substitutes composed of demineralized bone matrix in a reverse phase medium. Puros DBM with RPM products are designed to stimulate natural bone formation processes, in which mesenchymal cells differentiate into bone-forming cells. Puros DBM with RPM products contain a unique reverse phase medium, allowing the allograft to be malleable at operating room temperatures, while causing the product to stiffen when placed in the operating site. This property helps contains the DBM at the surgical site with minimal loss through irrigation and suction. About Puros DBM Block and Strip: Puros DBM Block and Strip are unique bone graft substitutes composed of 100% demineralized cancellous bone. These allografts are ideal natural scaffolds for new bone growth because they are processed to retain osteoinductive properties by preserving endogenous growth factors including BMP2, BMP4 and BMP7 to help support new bone formation. These allografts are used during surgical procedures to help promote bone growth and joint stability. Puros DBM Block and Strip are flexible and compressible once rehydrated, and are available in a variety of sizes and shapes to reduce transplant preparation time. The Puros DBM with RPM Putty, Putty with Chips, Gel and Paste, and Puros DBM Block and Strip products will be on display at the American Association for Neurological Surgeons (AANS) meeting being held April 5-9 in San Francisco at the Zimmer Spine Booth #1615.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ZMH:US $103.16 USD +0.99

ZMH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Boston Scientific Corp $13.02 USD +0.17
Cerner Corp $55.97 USD +1.62
Hospira Inc $50.66 USD -0.12
Smith & Nephew PLC 1,059 GBp +11.00
St Jude Medical Inc $67.06 USD +0.01
View Industry Companies
 

Industry Analysis

ZMH

Industry Average

Valuation ZMH Industry Range
Price/Earnings 23.0x
Price/Sales 3.7x
Price/Book 2.7x
Price/Cash Flow 22.4x
TEV/Sales 3.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZIMMER HOLDINGS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.